WallStSmart
CAI

Caris Life Sciences, Inc. Common Stock

NASDAQ: CAI · HEALTHCARE · BIOTECHNOLOGY

$17.77
-3.63% today

Updated 2026-04-29

Market cap
$5.02B
P/E ratio
P/S ratio
6.19x
EPS (TTM)
$-3.22
Dividend yield
52W range
$16 – $43
Volume
2.3M

Caris Life Sciences, Inc. Common Stock (CAI) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 4
Last 4 quarters
Avg EPS surprise
+45.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+0.8%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-21.1%
2025-11-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-26$0.28+180.0%$18.31$20.14+10.0%
2025-11-05$0.08+157.1%$31.18$24.61-21.1%
2025-08-12$-1.11-404.5%$30.21$34.28+13.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.10$0.28+180.0%$292.89M
2025-09-30$-0.14$0.08+157.1%$216.83M
2025-06-30$-0.22$-1.11-404.5%$181.40M
2025-03-31$0.00$-0.35$120.92M

Frequently asked questions

Has Caris Life Sciences, Inc. Common Stock beaten earnings estimates?
Caris Life Sciences, Inc. Common Stock has beaten Wall Street EPS estimates in 2 of its last 4 quarterly reports, with an average EPS surprise of +45.7% over the last 3 quarters.
How does CAI stock react to earnings?
CAI stock has moved an average of +0.8% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.